Milan, Italy

Gianluigi Condorelli

This inventor holds 2 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Humanitas Mirasole S.p.a., Humanitas University. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gianluigi Condorelli. Retrieved from https://idiyas.com/inventor/gianluigi-condorelli-c8khjmty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gianluigi Condorelli: Innovator in Cardiac Therapeutics

Introduction

Gianluigi Condorelli is a notable inventor based in Milan, Italy. He has made significant contributions to the field of cardiac therapeutics, particularly through his innovative patent related to T cell activation.

Latest Patents

Gianluigi Condorelli holds a patent titled "Therapeutic use of inhibitors of inhibitors of T cell activation or stimulation." This invention focuses on the use of inhibitors of T cell costimulation and/or activation and/or function in the treatment and/or prevention of cardiac pathologies, especially heart failure diseases, and/or related symptoms. He has 1 patent to his name.

Career Highlights

Throughout his career, Gianluigi has worked with esteemed organizations such as Humanitas Mirasole S.p.a. and Humanitas University. His work in these institutions has allowed him to advance his research and contribute to the medical field.

Collaborations

Gianluigi has collaborated with notable colleagues, including Marinos Kallikourdis and Elisa Martini. Their joint efforts have furthered research in the area of cardiac health and therapeutic interventions.

Conclusion

Gianluigi Condorelli's innovative work in cardiac therapeutics highlights his commitment to improving health outcomes through scientific research. His contributions are significant in the ongoing quest to address heart-related diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…